Baolingbao Biology Co.,Ltd. (002286.SZ)
CNY 7.94
(-1.24%)
CNY 7.94
(-1.24%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 218.49 Million CNY | -22.54% |
| 2022 | 292.34 Million CNY | -18.05% |
| 2021 | 367.32 Million CNY | 107.67% |
| 2020 | 174.67 Million CNY | -7.7% |
| 2019 | 174.52 Million CNY | 6.62% |
| 2018 | 166.14 Million CNY | 20.01% |
| 2017 | 136.55 Million CNY | -2.08% |
| 2016 | 135.3 Million CNY | 26.96% |
| 2015 | 105.35 Million CNY | 39.74% |
| 2014 | 74.56 Million CNY | -20.62% |
| 2013 | 107.99 Million CNY | -23.82% |
| 2012 | 135.24 Million CNY | 15.52% |
| 2011 | 117.21 Million CNY | 17.67% |
| 2010 | 97.8 Million CNY | -5.62% |
| 2009 | 105.46 Million CNY | -0.07% |
| 2008 | 106.15 Million CNY | 16.52% |
| 2007 | 91.39 Million CNY | 51.41% |
| 2006 | 58.99 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 29.57 Million CNY | 53.15% |
| 2024 Q3 | 41.29 Million CNY | -53.79% |
| 2024 Q2 | 80.75 Million CNY | 44.11% |
| 2023 Q4 | 17.23 Million CNY | -27.43% |
| 2023 Q2 | 30.48 Million CNY | 4.62% |
| 2023 Q3 | 23.74 Million CNY | -22.11% |
| 2023 FY | - CNY | -22.54% |
| 2023 Q1 | 29.13 Million CNY | -11.85% |
| 2022 Q3 | 29.04 Million CNY | -55.91% |
| 2022 Q2 | 65.87 Million CNY | 20.37% |
| 2022 Q1 | 54.72 Million CNY | 10.39% |
| 2022 FY | - CNY | -18.05% |
| 2022 Q4 | 33.05 Million CNY | 13.78% |
| 2021 Q3 | 110.35 Million CNY | 58.83% |
| 2021 Q4 | 49.57 Million CNY | -55.07% |
| 2021 Q1 | 17.44 Million CNY | 231.98% |
| 2021 FY | - CNY | 107.67% |
| 2021 Q2 | 69.47 Million CNY | 298.25% |
| 2020 Q4 | 5.25 Million CNY | -50.51% |
| 2020 Q2 | 36.74 Million CNY | 78.81% |
| 2020 Q1 | 20.54 Million CNY | 64.44% |
| 2020 FY | - CNY | -7.7% |
| 2020 Q3 | 10.61 Million CNY | -71.1% |
| 2019 Q3 | 25.12 Million CNY | -7.43% |
| 2019 FY | - CNY | 6.62% |
| 2019 Q1 | 21.4 Million CNY | 33.92% |
| 2019 Q2 | 27.14 Million CNY | 26.84% |
| 2019 Q4 | 12.49 Million CNY | -50.27% |
| 2018 FY | - CNY | 20.01% |
| 2018 Q2 | 36.08 Million CNY | 79.85% |
| 2018 Q4 | 15.97 Million CNY | -2.0% |
| 2018 Q1 | 20.06 Million CNY | -4.4% |
| 2018 Q3 | 16.3 Million CNY | -54.81% |
| 2017 Q3 | 8.15 Million CNY | -73.24% |
| 2017 FY | - CNY | -2.08% |
| 2017 Q4 | 20.98 Million CNY | 157.17% |
| 2017 Q2 | 30.49 Million CNY | 73.14% |
| 2017 Q1 | 17.61 Million CNY | -40.29% |
| 2016 Q3 | 11.03 Million CNY | -65.11% |
| 2016 Q1 | 9.79 Million CNY | -65.43% |
| 2016 Q2 | 31.63 Million CNY | 222.85% |
| 2016 Q4 | 29.49 Million CNY | 167.24% |
| 2016 FY | - CNY | 26.96% |
| 2015 FY | - CNY | 39.74% |
| 2015 Q4 | 28.33 Million CNY | 7272.75% |
| 2015 Q3 | 384.36 Thousand CNY | -98.62% |
| 2015 Q2 | 27.86 Million CNY | 124.11% |
| 2015 Q1 | 12.43 Million CNY | -29.5% |
| 2014 Q1 | 6.93 Million CNY | -64.1% |
| 2014 FY | - CNY | -20.62% |
| 2014 Q4 | 17.63 Million CNY | 1251.37% |
| 2014 Q3 | -1.53 Million CNY | -105.97% |
| 2014 Q2 | 25.67 Million CNY | 270.42% |
| 2013 Q3 | 12.51 Million CNY | -26.84% |
| 2013 FY | - CNY | -23.82% |
| 2013 Q1 | 15.55 Million CNY | -34.35% |
| 2013 Q4 | 19.3 Million CNY | 54.31% |
| 2013 Q2 | 17.1 Million CNY | 9.93% |
| 2012 Q1 | 17.06 Million CNY | 7.4% |
| 2012 Q2 | 28.12 Million CNY | 64.8% |
| 2012 FY | - CNY | 15.52% |
| 2012 Q4 | 23.69 Million CNY | -0.9% |
| 2012 Q3 | 23.91 Million CNY | -14.98% |
| 2011 Q4 | 15.88 Million CNY | -37.29% |
| 2011 Q1 | 9.74 Million CNY | -49.69% |
| 2011 Q2 | 31.8 Million CNY | 226.31% |
| 2011 Q3 | 25.33 Million CNY | -20.34% |
| 2011 FY | - CNY | 17.67% |
| 2010 Q3 | 19.02 Million CNY | -10.79% |
| 2010 FY | - CNY | -5.62% |
| 2010 Q4 | 19.37 Million CNY | 1.84% |
| 2010 Q1 | 17.51 Million CNY | 3.81% |
| 2010 Q2 | 21.32 Million CNY | 21.74% |
| 2009 Q1 | 13.96 Million CNY | -31.27% |
| 2009 Q4 | 16.87 Million CNY | -8.53% |
| 2009 Q2 | 27.94 Million CNY | 100.15% |
| 2009 Q3 | 18.44 Million CNY | -33.99% |
| 2009 FY | - CNY | -0.07% |
| 2008 Q3 | 22.1 Million CNY | 0.0% |
| 2008 Q4 | 20.31 Million CNY | -8.1% |
| 2008 FY | - CNY | 16.52% |
| 2007 FY | - CNY | 51.41% |
| 2006 FY | - CNY | 0.0% |